Philips Electronics Nederland B.V. was awarded a $2.5M contract last week by the Defense Advanced Research Projects Agency (DARPA). The contract was part of an effort called Autonomous Diagnostics to Enable Prevention and Therapeutics: Diagnostics on Demand in Limited Resource Settings (ADEPT: DxOD-LRS). The DARPA program was introduced last year under a Broad Agency Announcement (DARPA-BAA-11-39).
Under the BAA, DARPA requested innovative research proposals for the development of on-site critical diagnostics tailored for rapid, self-performed tests deployable with military personnel into limited resource settings. The funding effort was designed to develop and demonstrate clinically valid devices for the detection of multiple analytes in relevant self-collected bio-specimens. The DxOD-LRS effort aims to significantly advance point-of-need diagnostics and enable development of capabilities that far exceed current technologies. The end goal of the program is to bring funded proposals to an “Alpha-level” prototype device (Technology Readiness Level 5).
Philips Electronics Nederland B.V. is based in Eindhoven, the Netherlands. Philips Electronics Nederland B.V. operates as a subsidiary of Koninklijke Philips Electronics NV.
